GC-021109

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameGC-021109
Drug Alias NameGC-021109
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPyrimidinergic receptor P2Y6 agonists
TargetsPyrimidinergic receptor P2Y6
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTufts University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGliacure Inc
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A